Skip to content

Clinical trials

Completed Phase 3 Epilepsies, Partial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsies, Partial Phase: Phase 3 Status: Completed Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20023
20049
20052
20066
20073
20087
20093
20111
20121
20131
20141
20161
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer7
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.7
SK Life Science, Inc.7
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.6
UCB Pharma5
Bial - Portela C S.A.4
GlaxoSmithKline3
UCB BIOSCIENCES, Inc.3
Supernus Pharmaceuticals, Inc.2
UCB Japan Co. Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsies, Partial51
Epilepsy31
Seizures24
Epilepsy, Complex Partial8
Epilepsy, Generalized3
Epilepsy, Partial, Motor2
Brain Diseases1
Epilepsy, Tonic-Clonic1
Sleep Deprivation1
Weight Loss1

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.